Clinical mutational profiling of PTOL tumors revealed the same frequency of oncogene (e.g. KRAS) and tumor suppressor gene (e.g. TP53) mutations as the general pancreatic cancer population (Table 1). Here, TP53 is linked to familial pancreatic carcinoma.